by Sam Eskandari | Aug 15, 2018 | News
August 15, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with IsCann Group Limited (“IsCann”) located in Be’er...
by Sam Eskandari | Aug 13, 2018 | News
VANCOUVER, British Columbia, Aug. 13, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with the Chamber of Commerce, Industry,...
by Sam Eskandari | Aug 8, 2018 | News
VANCOUVER, British Columbia, Aug. 08, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Clearstream Banking, a major central securities depository based in Frankfurt, Germany, which...
by Sam Eskandari | Jul 27, 2018 | News
VANCOUVER, British Columbia, July 27, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that effective June 25, 2018, it cancelled a total of 3,272,000 incentive stock options (“Options”)...
by Sam Eskandari | Jul 17, 2018 | News
VANCOUVER, British Columbia, July 17, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property Sharing Agreement (“Joint IP”) with Sativa Investments PLC...
by Sam Eskandari | Jun 26, 2018 | News
VANCOUVER, British Columbia, June 25, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios Theodorou has been appointed as its business development agent in Cyprus. He will report...
